Medicare billing address
CMS Medicare provider billing file
4060 Butler PikeSuite 200
Plymouth Meeting, PA 19462
CMS public data · NPI 1700850179
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Arunan Sivalingam, M.D.
Specialty
Credential
M.D.
NPI
1700850179
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Arunan Sivalingam, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
4060 Butler PikeCMS Doctors & Clinicians file
300 Plaza CtCMS Doctors & Clinicians file
1523 Concord PikeCMS Doctors & Clinicians file
8 Ranoldo TerIn the 2024 CMS provider billing file, this NPI had 1,484 Medicare beneficiaries and 36,373 total services. The average beneficiary age was 77, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$6,453,993.15
Total Medicare payment amount
$5,095,847.41
Medicare beneficiaries
1,484
Total services
36,373
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Ischemic heart disease
32%
CMS beneficiary-panel share
Chronic kidney disease
28%
CMS beneficiary-panel share
Anxiety
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 9,900 | $34.49 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 6,955 | $226.66 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 4,290 | $147.01 |
| Imaging of retina | 4,191 | $43.61 |
| Injection of drug into eye | 2,980 | $137.21 |
| Injection, aflibercept, 1 mg | 2,885 | $825.60 |
| Established patient problem focused exam of visual system | 2,531 | $95.93 |
| Injection, aflibercept hd, 1 mg | 1,056 | $329.26 |
| Established patient complete exam of visual system | 730 | $134.79 |
| Extended exam of the back part of the eye with retinal drawing | 177 | $25.76 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1700850179. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisolone Acetate | Prednisolone Acetate | 168 | 329 | $7,290.97 |
| 2 | Ketorolac Tromethamine | Ketorolac Tromethamine | 144 | 225.7 | $3,460.85 |
| 3 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 51 | 121.1 | $712.28 |
| 4 | Acetazolamide | Acetazolamide | 40 | 66 | $724.06 |
| 5 | Timolol Maleate | Timolol Maleate | 32 | 63.5 | $285.07 |
| 6 | Erythromycin | Erythromycin Base | 26 | 28 | $341.37 |
| 7 | Dorzolamide Hcl | Dorzolamide Hcl | 16 | 26.7 | $145.17 |
| 8 | Brimonidine Tartrate | Brimonidine Tartrate | 15 | 42.5 | $3,288.45 |
| 9 | Latanoprost | Latanoprost | 13 | 21.9 | $188.81 |
| 10 | Eylea | Aflibercept | 12 | 12 | $33,170.27 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Rutgers School Of Dental Medicine
Graduation year
1985
Group/practice field
Retinovitreous Associates Ltd
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.